Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer

J Thorac Oncol. 2006 Nov;1(9):1040-1.

Authors

Judith Elizabeth Carser¹, Yvonne Jane Summers

Affiliation

¹ Department of Medical Oncology, Northern Ireland Cancer Centre, Belfast, Northern Ireland. [email protected]

PMID: 17409992

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Biopsy, Needle
Bronchoscopy
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / pathology
Dose-Response Relationship, Drug
Drug Administration Schedule
Erlotinib Hydrochloride
Eyelashes / growth & development*
Female
Follow-Up Studies
Humans
Hypertrichosis / chemically induced*
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Middle Aged
Neoplasm Staging
Quinazolines / adverse effects*
Quinazolines / therapeutic use
Risk Assessment
Tomography, X-Ray Computed
Treatment Outcome

Substances

Quinazolines
Erlotinib Hydrochloride